[1]
“The Impact of Very Late Antigen 4 Polymorphism on Drug Responsiveness in Patients with Multiple Sclerosis Initiation”, IRAQI JMS, vol. 20, no. 1, Jun. 2022, Accessed: May 10, 2025. [Online]. Available: https://iraqijms.net/index.php/jms/article/view/818